NFJ Investment Group’s West Pharmaceutical WST Stock Holding History

NFJ Investment Group’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.76M	Buy	21,614 +8	+0%	+$2.45K	0.26%	90
2026 Q1	$5.42M	Buy	+21,606	New	+$5.38M	0.21%	94
2023 Q2	–	Sell	-2,024	Closed	-$701K	–	297
2023 Q1	$701K	Sell	2,024 -140,495	-99%	-$41.1M	0.02%	246
2022 Q4	$33.5M	Sell	142,519 -50,631	-26%	-$12M	0.88%	29
2022 Q3	$36.2M	Buy	193,150 +134,095	+227%	+$40.9M	0.95%	19
2022 Q2	$17.9M	Buy	59,055 +751	+1%	+$244K	0.43%	77
2022 Q1	$23.9M	Sell	58,304 -1,893	-3%	-$741K	0.49%	68
2021 Q4	$28.2M	Buy	60,197 +8,339	+16%	+$3.59M	0.52%	57
2021 Q3	$22M	Sell	51,858 -1,616	-3%	-$681K	0.43%	66
2021 Q2	$19.2M	Buy	53,474 +19,523	+58%	+$6.45M	0.36%	85
2021 Q1	$9.57M	Buy	+33,951	New	+$9.72M	0.19%	155

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

NFJ Investment Group's WST Position: Q2 2026 in Review

NFJ Investment Group increased its West Pharmaceutical (WST) stake by 0.04% in Q2 2026, buying an estimated $2.45K and bringing the position to 21,614 shares worth $7.76M. The position accounts for 0.26% of the portfolio, ranked #90.

NFJ Investment Group first reported a position in WST in Q1 2021 and has held it in 11 quarters since. The position peaked at $36.2M in Q3 2022. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

NFJ Investment Group held 21,614 shares of West Pharmaceutical worth $7.76M as of Q2 2026.
NFJ Investment Group bought 8 West Pharmaceutical shares in Q2 2026, an estimated $2.45K.
West Pharmaceutical made up 0.26% of NFJ Investment Group's portfolio in Q2 2026, its #90 holding.
NFJ Investment Group first reported a position in West Pharmaceutical in Q1 2021 and has held it in 11 quarters since.
NFJ Investment Group's West Pharmaceutical position peaked at $36.2M in Q3 2022.
830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on NFJ Investment Group's 13F filing for Q2 2026, filed 11 Aug 2026.